2012
DOI: 10.1016/j.radonc.2011.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy treatment of keloid scars with a kilovoltage X-ray parallel pair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 10 publications
0
11
0
Order By: Relevance
“…To date, X-ray still acts as an adjuvant role in new combination therapies. [3738] X-ray was generated by an electron-exciting device and customarily delivers superficial low-dose radiation toward the lesions. Originally, radiation therapists use 100–400 keV; however, low-energy X-ray resulted with more acute skin side effects.…”
Section: Different Radiations Keloids and Strategiesmentioning
confidence: 99%
See 1 more Smart Citation
“…To date, X-ray still acts as an adjuvant role in new combination therapies. [3738] X-ray was generated by an electron-exciting device and customarily delivers superficial low-dose radiation toward the lesions. Originally, radiation therapists use 100–400 keV; however, low-energy X-ray resulted with more acute skin side effects.…”
Section: Different Radiations Keloids and Strategiesmentioning
confidence: 99%
“…Moreover, due to homogeneous earlobe sites, 60 kV and 120 kV beams achieved homogeneity of two separated but close lesions treatment, with the satisfaction rating of 4.7/5. [41]…”
Section: Different Radiations Keloids and Strategiesmentioning
confidence: 99%
“…In clinical conditions, the depth of underlying material may be limited by lack of tissue (for example, treatment of keloids on the pinna of the ear (7) ) and BSF may be greatly reduced in these circumstances. Lead shielding is sometimes used behind the target volume, which can lead to both dose reduction from lack of underlying tissue and dose enhancement at short distances because of backscatter from the lead.…”
Section: Introductionmentioning
confidence: 99%
“…70,71 In a recent survey of non-melanoma skin cancer, 81% of respondents used kilovoltage therapy. 70 A retrospective analysis of 1715 lesions treated over 10 years (including the past 2 years with the SRT-100 unit) found 5-year recurrence rates of 4.2% for basal cell carcinoma (BCC) and 5.8% for squamous cell carcinoma (SCC) tumours.…”
Section: Clinical Applications Skinmentioning
confidence: 99%